2021
DOI: 10.1039/d0sc04727a
|View full text |Cite
|
Sign up to set email alerts
|

All-in-one mitochondria-targeted NIR-II fluorophores for cancer therapy and imaging

Abstract: Small-molecule subcellular organelle-targeting theranostics are crucial for early disease diagnosis and treatment. The imaging window of these molecules are mainly focused on visible and near infrared (below ~ 900 nm)...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
51
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 65 publications
(51 citation statements)
references
References 71 publications
0
51
0
Order By: Relevance
“…The donor-acceptor-donor (D-A-D) architecture based on a BBTD core, has been previously used to successfully construct small molecule-based NIR-II fluorophores. 50 However, these NIR-II πelectron conjugated luminophores are easily prone to aggregation-caused quenching (ACQ) in the aggregation state, in which subsequently suppresses fluorescence emission during bioimaging. [51][52][53] In the present study, we optimized QYs of small molecule-based NIR-II imaging agents, with the aim of extending the emission wavelength of AIEgens in the NIR-IIb region.…”
Section: Resultsmentioning
confidence: 99%
“…The donor-acceptor-donor (D-A-D) architecture based on a BBTD core, has been previously used to successfully construct small molecule-based NIR-II fluorophores. 50 However, these NIR-II πelectron conjugated luminophores are easily prone to aggregation-caused quenching (ACQ) in the aggregation state, in which subsequently suppresses fluorescence emission during bioimaging. [51][52][53] In the present study, we optimized QYs of small molecule-based NIR-II imaging agents, with the aim of extending the emission wavelength of AIEgens in the NIR-IIb region.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, H4‐PEG‐Glu demonstrated a highly synergistic chemotherapeutic photothermal effect in vivo, and was the first to specifically image tumors in AML patient‐derived PDX mouse models. [ 57 ]…”
Section: Nir‐ii Fluorescence Imagingmentioning
confidence: 99%
“…In addition, H4-PEG-Glu demonstrated a highly synergistic chemotherapeutic photothermal effect in vivo, and was the first to specifically image tumors in AML patientderived PDX mouse models. [57] In addition, the dyes used for NIR-II imaging include IR-FE and Q4, which have similar structural systems. As shown in Figure 9a ) Chemical structure of CH1055 and the one-step sulfonation to produce CH-4T.…”
Section: Organic Fluorescent Moleculesmentioning
confidence: 99%
“…One modality that appears attractive for combination with deferasirox is photothermal therapy (PTT), which relies on photonic energy to generate local hyperthermia to damage cancer cells [ [22] , [23] , [24] ]. PTT takes advantage of the susceptibility of cancer cells toward heat to induce apoptosis [ 25 , 26 ]. Especially, because of its O 2 -independent mechanism of action, PTT has emerged as an important strategy for improving the sensibility of conventional cancer treatments, such as radio- and chemotherapy [ [27] , [28] , [29] , [30] ].…”
Section: Introductionmentioning
confidence: 99%